|
TMBIM6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43919999753928E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0787000004342E-07 |
| Normal-vs-Stage2 |
6.43449999999657E-05 |
| Normal-vs-Stage3 |
1.042390E-02 |
| Normal-vs-Stage4 |
2.244500E-02 |
| Stage1-vs-Stage2 |
9.405200E-01 |
| Stage1-vs-Stage3 |
6.471700E-02 |
| Stage1-vs-Stage4 |
6.478600E-01 |
| Stage2-vs-Stage3 |
1.162350E-01 |
| Stage2-vs-Stage4 |
6.213000E-01 |
| Stage3-vs-Stage4 |
5.193000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.49159999801785E-08 |
| Normal-vs-AfricanAmerican |
1.87368999999826E-05 |
| Normal-vs-Asian |
6.667900E-02 |
| Caucasian-vs-AfricanAmerican |
5.662600E-01 |
| Caucasian-vs-Asian |
8.928600E-01 |
| AfricanAmerican-vs-Asian |
9.505000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.75549999484426E-08 |
| Normal-vs-Female |
2.44039999999224E-05 |
| Male-vs-Female |
3.934000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.83680000000108E-05 |
| Normal-vs-Extreme_Weight |
6.84629997138586E-09 |
| Normal-vs-Obese |
2.570800E-04 |
| Normal-vs-Extreme_Obese |
1.343070E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.362600E-01 |
| Normal_Weight-vs-Obese |
2.890800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.681600E-01 |
| Extreme_Weight-vs-Obese |
2.896300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.451600E-01 |
| Obese-vs-Extreme_Obese |
2.220400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.854110E-02 |
| Normal-vs-Age(41-60Yrs) |
3.14599999995391E-06 |
| Normal-vs-Age(61-80Yrs) |
7.55520002115873E-09 |
| Normal-vs-Age(81-100Yrs) |
1.283780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.470000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.135240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.897000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.777700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.151800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.357800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72730999999926E-05 |
| Normal-VS-Type2 PRCC |
2.386900E-04 |
| Normal-VS-KIRP CIMP |
1.394390E-02 |
| Normal-VS-Unclassified PRCC |
3.515900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.183700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.773600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.482400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.693800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.443000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.795800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.793519999993E-05 |
| Normal-vs-N1 |
9.598900E-03 |
| Normal-vs-N2 |
2.906600E-01 |
| N0-vs-N1 |
2.451400E-01 |
| N0-vs-N2 |
3.620400E-01 |
| N1-vs-N2 |
7.576600E-01 |
|
|
